Abiomed, Inc. (ABMD)
- Previous Close
381.02 - Open
380.78 - Bid 381.31 x 1000
- Ask 381.50 x 900
- Day's Range
380.55 - 381.28 - 52 Week Range
219.85 - 381.99 - Volume
15,702,662 - Avg. Volume
1,703,123 - Market Cap (intraday)
17.181B - Beta (5Y Monthly) --
- PE Ratio (TTM)
65.36 - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Related News
Performance Overview: ABMD
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ABMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ABMD
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: ABMD
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: ABMD
ABMD: Raising target price to $400.00
ABIOMED INC has an Investment Rating of HOLD; a target price of $400.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.
RatingNeutralPrice TargetABMD: Raising target price to $397.00
ABIOMED INC has an Investment Rating of HOLD; a target price of $397.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
RatingNeutralPrice TargetABMD: Lowering target price to $396.00
ABIOMED INC has an Investment Rating of HOLD; a target price of $396.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingNeutralPrice TargetABMD: Raising target price to $397.00
ABIOMED INC has an Investment Rating of HOLD; a target price of $397.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingNeutralPrice Target